We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$249M
Cap. Flow
+$50.8M
Cap. Flow %
2.05%
Top 10 Hldgs %
26.01%
Holding
1,560
New
411
Increased
288
Reduced
223
Closed
552

Top Buys

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$28.4M
2
EGLE
Eagle Bulk Shipping Inc.
EGLE
+$26.4M
3
RCM
R1 RCM Inc. Common Stock
RCM
+$26M
4
TBPH icon
Theravance Biopharma
TBPH
+$25.2M
5
XLNX
Xilinx Inc
XLNX
+$14.8M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$46.1M
2
RP
RealPage, Inc.
RP
+$26.3M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$15M
4
CCK icon
Crown Holdings
CCK
+$14.2M
5
QS icon
QuantumScape Corp
QS
+$13.5M

Sector Composition

Rank Sector Weight
1 Healthcare 9.96%
2 Industrials 4.3%
3 Technology 4.06%
4 Financials 3.71%
5 Communication Services 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CEREW
476
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$855K 0.03%
56,667
– –
XBI icon
477
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$851K 0.03%
6,200
-11,678
-65% -$1.54M
IIII
478
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
$839K 0.03%
86,401
+50,000
+137% +$492K
WDAY icon
479
PUT
Workday
WDAY
$33.4B
$836K 0.03%
3,500
+2,000
+133% +$481K
BMRN icon
480
CALL
BioMarin Pharmaceuticals
BMRN
$11.5B
$834K 0.03%
10,000
-28,500
-74% -$2.26M
BMRN icon
481
PUT
BioMarin Pharmaceuticals
BMRN
$11.5B
$834K 0.03%
10,000
-23,200
-70% -$1.84M
CAT icon
482
Caterpillar
CAT
$409B
$832K 0.03%
+3,823
New +$883K
PH icon
483
PUT
Parker-Hannifin
PH
$125B
$829K 0.03%
2,700
-800
-23% -$248K
SILJ icon
484
CALL
Amplify Junior Silver Miners ETF
SILJ
$3.27B
$827K 0.03%
54,400
+26,100
+92% +$424K
IPOD.U
485
DELISTED
Social Capital Hedosophia Holdings Corp. IV Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
IPOD.U
$825K 0.03%
75,000
– –
FCX icon
486
PUT
Freeport-McMoran
FCX
$90B
$809K 0.03%
21,800
-18,900
-46% -$736K
SYF icon
487
Synchrony
SYF
$23.7B
$809K 0.03%
16,673
-12,629
-43% -$576K
ONDS icon
488
Ondas Inc
ONDS
$4.44B
$806K 0.03%
100,000
+97,269
+3,562% +$765K
EEFT icon
489
Euronet Worldwide
EEFT
$3.02B
$803K 0.03%
5,894
+1,594
+37% +$232K
HD icon
490
Home Depot
HD
$332B
$800K 0.03%
+2,508
New +$798K
DYN icon
491
Dyne Therapeutics
DYN
$4.04B
$798K 0.03%
36,596
-54,966
-60% -$1.03M
AIZ icon
492
PUT
Assurant
AIZ
$13.7B
$797K 0.03%
+5,100
New +$797K
TRI icon
493
Thomson Reuters
TRI
$39.4B
$796K 0.03%
7,632
+199
+3% +$19.9K
CLRB icon
494
Cellectar Biosciences
CLRB
$19.3M
$793K 0.03%
2,167
-833
-28% -$361K
MCD icon
495
McDonald's
MCD
$188B
$790K 0.03%
+3,422
New +$796K
TLSI icon
496
TriSalus Life Sciences
TLSI
$259M
$789K 0.03%
80,681
+30,681
+61% +$301K
SMH icon
497
VanEck Semiconductor ETF
SMH
$67.6B
$786K 0.03%
5,992
-90,968
-94% -$11.2M
HAACU
498
DELISTED
Health Assurance Acquisition Corp. SAIL Securities
HAACU
$784K 0.03%
75,000
– –
IPG
499
PUT
DELISTED
Interpublic Group of Companies
IPG
$783K 0.03%
+24,100
New +$770K
MSI icon
500
PUT
Motorola Solutions
MSI
$69.4B
$781K 0.03%
3,600
+2,200
+157% +$439K
18 19
20
21 22

Similar funds

AUB
Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
KACA
Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
MIM
Merewether Investment Management Dallas, Texas $5.16B AUM 86.81% 1-Year Est. Return
AAI
Aequim Alternative Investments Mill Valley, California $5.16B AUM 9.8% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Maven Securities's Q2 2021 Portfolio in Review

As of Q2 2021, Maven Securities held 1,560 positions worth $2.48B, up 11% from $2.23B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Maven Securities's Q2 2021 filing shows 411 new, 288 increased, 223 reduced and 552 closed positions. Its largest new stake was Proofpoint, Inc.: 175,167 shares worth $30.4M. The largest sale was Invesco QQQ Trust, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 13% a quarter earlier, followed by Industrials and Technology.

  • Maven Securities's largest Q2 2021 buy was Proofpoint, Inc.: 175,167 shares worth $30.4M.
  • Maven Securities added most to Xilinx Inc in Q2 2021, an estimated $14.8M increase.
  • Maven Securities's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $46.1M.
  • Maven Securities fully exited RealPage, Inc. in Q2 2021, selling an estimated $26.3M.
  • Maven Securities's ten largest holdings make up 26% of its $2.48B portfolio in Q2 2021.
  • Maven Securities opened 411 new positions and closed 552 in Q2 2021.
  • Maven Securities's portfolio value rose 11% quarter-over-quarter to $2.48B.

Based on Maven Securities's 13F filing for Q2 2021, filed 16 Aug 2021.